Innovative Applications of Nanopore Technology in Tumor Screening: An Exosome-Centric Approach
Biosensors · 2025
DOI: 10.3390/bios15040199 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, 2025. Verfasst von Heng Chi und 4 weiteren Autor:innen. Beteiligte Einrichtung: BGI Research, Shenzhen 518083, China. Hauptthemen laut MEDLINE: Exosomes, Nanopores, Neoplasms, Biosensing Techniques. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Pioneer” and “Leading Goose” R&D Program of Zhejiang.
Abstract (Originalsprache)
Cancer remains one of the leading causes of death worldwide. Its complex pathogenesis and metastasis pose significant challenges for early diagnosis, underscoring the urgent need for innovative and non-invasive tumor screening methods. Exosomes, small extracellular vesicles that reflect the physiological and pathological states of their parent cells, are uniquely suited for cancer liquid biopsy due to their molecular cargo, including RNA, DNA, and proteins. However, traditional methods for exosome isolation and detection are often limited by inadequate sensitivity, specificity, and efficiency. Nanopore technology, characterized by high sensitivity and single-molecule resolution, offers powerful tools for exosome analysis. This review highlights its diverse applications in tumor screening, such as magnetic nanopores for high-throughput sorting, electrochemical sensing for real-time detection, nanomaterial-based assemblies for efficient capture, and plasmon resonance for ultrasensitive analysis. These advancements have enabled precise exosome detection and demonstrated promising potential in the early diagnosis of breast, pancreatic, and prostate cancers, while also supporting personalized treatment strategies. Additionally, this review summarizes commercialized products for exosome-based cancer diagnostics and examines the technical and translational challenges in clinical applications. Finally, it discusses the future prospects of nanopore technology in advancing liquid biopsy toward clinical implementation. The continued progress of nanopore technology not only accelerates exosome-based precision medicine but also represents a significant step forward in next-generation liquid biopsy and tumor screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- BGI Research, Shenzhen 518083, China.
- BGI Research, Hangzhou 310030, China.
- BGI Research, Qingdao 266555, China.
ORCID-Profile: Heng Chi, Liuxin Shi, Songlin Gan
Förderung
- “Pioneer” and “Leading Goose” R&D Program of Zhejiang
Zitieren
APA
Chi, H., Shi, L., Gan, S., Fan, G., & Dong, Y. (2025). Innovative Applications of Nanopore Technology in Tumor Screening: An Exosome-Centric Approach. Biosensors. https://doi.org/10.3390/bios15040199
Vancouver
Chi H, Shi L, Gan S, Fan G, Dong Y. Innovative Applications of Nanopore Technology in Tumor Screening: An Exosome-Centric Approach. Biosensors. 2025. doi:10.3390/bios15040199
BibTeX
@article{Chi2025,
author = {Chi, Heng and Shi, Liuxin and Gan, Songlin and Fan, Guangyi and Dong, Yuliang},
title = {Innovative Applications of Nanopore Technology in Tumor Screening: An Exosome-Centric Approach},
journal = {Biosensors},
year = {2025},
doi = {10.3390/bios15040199}
}
EUVIMED